MentionFox
Home › Executive changes › Oragenics Inc
Leadership changes · SEC Form 8-K, Item 5.02

Oragenics Inc executive changes

Every leadership change Oragenics Inc reported to the SEC under Item 5.02: who left, who was appointed, to what role and from when, quoted from each filing.

Filings1
Appointments named1
Latest filing2026-07-06

Oragenics Inc filed 1 current report with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-07-06. Between them they name 1 person. Each change below is quoted from the filing and linked to it.

Every change, newest first

Filed 2026-07-06 · 8-K

Appointed: John Spencer, Chief Financial Officer, effective 2026-07-01

Effective July 1, 2026, the Board appointed John Spencer, the Company's Senior Controller, to serve as the Company's Chief Financial Officer.
Hiring for a seat like this?

Find people with the same kind of experience as the Chief Financial Officer at Oragenics Inc, with the record behind each one.

Find candidates like Chief Financial Officer at Oragenics Inc
Selling to Oragenics Inc?

New leaders review vendors and budgets in their first months. Get an alert the next time Oragenics Inc is in the news or changes leadership.

Get an alert when Oragenics Inc changes leadership

Tools for this story

Each opens in a new tab, filled in for Oragenics Inc. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/oragenics
Last updated 2026-09-27
Primary record: SEC filing
Oragenics Inc (OGEN) executive changes: John Spencer appointed, Chief Financial Officer. MentionFox, 2026-09-27. https://mentionfox.com/executive-changes/oragenics